Literature DB >> 23836236

Pathogenesis of chronic viral hepatitis: differential roles of T cells and NK cells.

Barbara Rehermann1.   

Abstract

Chronic hepatitis B virus (HBV) and hepatitis C virus (HCV) infections account for 57% of cases of liver cirrhosis and 78% of cases of primary liver cancer worldwide and cause a million deaths per year. Although HBV and HCV differ in their genome structures, replication strategies and life cycles, they have common features, including their noncytopathic nature and their capacity to induce chronic liver disease, which is thought to be immune mediated. However, the rate of disease progression from chronic hepatitis to cirrhosis varies greatly among infected individuals, and the factors that regulate it are largely unknown. This review summarizes our current understanding of the roles of antigen-specific and nonspecific immune cells in the pathogenesis of chronic hepatitis B and C and discusses recent findings that identify natural killer cells as regulators of T cell function and liver inflammation.

Entities:  

Mesh:

Year:  2013        PMID: 23836236      PMCID: PMC4482132          DOI: 10.1038/nm.3251

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


  165 in total

1.  Hepatitis C virus (HCV)-specific CD8+ cells produce transforming growth factor beta that can suppress HCV-specific T-cell responses.

Authors:  Nadia Alatrakchi; Camilla S Graham; Hans J J van der Vliet; Kenneth E Sherman; Mark A Exley; Margaret James Koziel
Journal:  J Virol       Date:  2007-03-21       Impact factor: 5.103

2.  Characterization of hepatitis B virus (HBV)-specific T-cell dysfunction in chronic HBV infection.

Authors:  Carolina Boni; Paola Fisicaro; Caterina Valdatta; Barbara Amadei; Paola Di Vincenzo; Tiziana Giuberti; Diletta Laccabue; Alessandro Zerbini; Albertina Cavalli; Gabriele Missale; Antonio Bertoletti; Carlo Ferrari
Journal:  J Virol       Date:  2007-02-07       Impact factor: 5.103

Review 3.  Immunobiology and pathogenesis of viral hepatitis.

Authors:  Luca G Guidotti; Francis V Chisari
Journal:  Annu Rev Pathol       Date:  2006       Impact factor: 23.472

Review 4.  Starring stellate cells in liver immunology.

Authors:  Florian Winau; Christian Quack; Alexandre Darmoise; Stefan H E Kaufmann
Journal:  Curr Opin Immunol       Date:  2007-12-18       Impact factor: 7.486

5.  Human leukocyte antigen-associated sequence polymorphisms in hepatitis C virus reveal reproducible immune responses and constraints on viral evolution.

Authors:  Joerg Timm; Bin Li; Marcus G Daniels; Tanmoy Bhattacharya; Laura L Reyor; Rachel Allgaier; Thomas Kuntzen; Will Fischer; Brian E Nolan; Jared Duncan; Julian Schulze zur Wiesch; Arthur Y Kim; Nicole Frahm; Christian Brander; Raymond T Chung; Georg M Lauer; Bette T Korber; Todd M Allen
Journal:  Hepatology       Date:  2007-08       Impact factor: 17.425

Review 6.  Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver.

Authors:  Scott L Friedman
Journal:  Physiol Rev       Date:  2008-01       Impact factor: 37.312

7.  Cytokines induced during chronic hepatitis B virus infection promote a pathway for NK cell-mediated liver damage.

Authors:  Claire Dunn; Maurizia Brunetto; Gary Reynolds; Theodoros Christophides; Patrick T Kennedy; Pietro Lampertico; Abhishek Das; A Ross Lopes; Persephone Borrow; Kevin Williams; Elizabeth Humphreys; Simon Afford; David H Adams; Antonio Bertoletti; Mala K Maini
Journal:  J Exp Med       Date:  2007-03-12       Impact factor: 14.307

8.  TLR-dependent cross talk between human Kupffer cells and NK cells.

Authors:  Zhengkun Tu; Adel Bozorgzadeh; Robert H Pierce; Jonathan Kurtis; I Nicholas Crispe; Mark S Orloff
Journal:  J Exp Med       Date:  2008-01-14       Impact factor: 14.307

9.  High basal STAT4 balanced by STAT1 induction to control type 1 interferon effects in natural killer cells.

Authors:  Takuya Miyagi; M Pilar Gil; Xin Wang; Jennifer Louten; Wen-Ming Chu; Christine A Biron
Journal:  J Exp Med       Date:  2007-09-10       Impact factor: 14.307

Review 10.  The trafficking of natural killer cells.

Authors:  Claude Grégoire; Lionel Chasson; Carmelo Luci; Elena Tomasello; Frédéric Geissmann; Eric Vivier; Thierry Walzer
Journal:  Immunol Rev       Date:  2007-12       Impact factor: 12.988

View more
  186 in total

1.  Monocytes activate natural killer cells via inflammasome-induced interleukin 18 in response to hepatitis C virus replication.

Authors:  Elisavet Serti; Jens M Werner; Michael Chattergoon; Andrea L Cox; Volker Lohmann; Barbara Rehermann
Journal:  Gastroenterology       Date:  2014-03-28       Impact factor: 22.682

2.  Nonalcoholic fatty liver disease is associated with lower hepatitis B viral load and antiviral response in pediatric population.

Authors:  Lu Wang; Yijin Wang; Shuhong Liu; Xiangwei Zhai; Guangde Zhou; Fengmin Lu; Jingmin Zhao
Journal:  J Gastroenterol       Date:  2019-05-27       Impact factor: 7.527

Review 3.  Hepatitis C virus-specific cytotoxic T cell response restoration after treatment-induced hepatitis C virus control.

Authors:  Juan-Ramón Larrubia; Elia Moreno-Cubero; Joaquín Miquel; Eduardo Sanz-de-Villalobos
Journal:  World J Gastroenterol       Date:  2015-03-28       Impact factor: 5.742

Review 4.  Tropism of human pegivirus (formerly known as GB virus C/hepatitis G virus) and host immunomodulation: insights into a highly successful viral infection.

Authors:  Ernest T Chivero; Jack T Stapleton
Journal:  J Gen Virol       Date:  2015-02-09       Impact factor: 3.891

5.  Outflanking HCV.

Authors:  Zhigang Tian
Journal:  Nat Immunol       Date:  2014-01       Impact factor: 25.606

Review 6.  Hepatitis B virus genotypes and variants.

Authors:  Chih-Lin Lin; Jia-Horng Kao
Journal:  Cold Spring Harb Perspect Med       Date:  2015-05-01       Impact factor: 6.915

7.  Genetic disruption of CD8+ Treg activity enhances the immune response to viral infection.

Authors:  Tobias A W Holderried; Philipp A Lang; Hye-Jung Kim; Harvey Cantor
Journal:  Proc Natl Acad Sci U S A       Date:  2013-12-09       Impact factor: 11.205

Review 8.  Immune responses to HCV and other hepatitis viruses.

Authors:  Su-Hyung Park; Barbara Rehermann
Journal:  Immunity       Date:  2014-01-16       Impact factor: 31.745

Review 9.  Hepatitis C virus: Is it time to say goodbye yet? Perspectives and challenges for the next decade.

Authors:  Heidi Barth
Journal:  World J Hepatol       Date:  2015-04-18

Review 10.  Revisiting Hepatitis B Virus: Challenges of Curative Therapies.

Authors:  Jianming Hu; Ulrike Protzer; Aleem Siddiqui
Journal:  J Virol       Date:  2019-09-30       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.